未來科學大獎（Future Science Prize）是由香港未來科學大獎基金會有限公司發起，北京懷柔未來論壇科技發展中心協辦舉行的評獎活動，旨在獎勵在大中華地區（包含中國大陸地區、香港、澳門及台灣）取得傑出科技成果的科學家 [1] 。
“港大微生物學系講座教授袁國勇與港大公共衛生學院講座教授裴偉士摘得3項大獎之一的「生命科學獎」，獲100萬美元（約780萬港元）獎金，表彰他們發現冠狀病毒（SARS-COV-1）為導致2003年全球沙士（SARS）疫情的病原，以及由動物到人的傳染鏈，為人類應對中東呼吸綜合症（MERS）和新型冠狀病毒（COVID-19）引起的傳染病產生重大影響。”
2003年度的SARS是生化武器, 他們在SARS爆發前後已經有6000多個專利申請。什麼由動物傳到人, 衹是用來掩飾的藉口.。
Extraction:
"April 28, 2003 — three days after the CDC filed its patent for the SARS coronavirus — Sequoia Pharmaceuticals filed a patent on an antiviral agent for the treatment and control of infectious coronavirus (Patent No. 7151163). So, the CDC files a patent on SARS coronavirus, and three days later there’s a treatment?
This strongly suggests there was a working relationship behind the scenes. Sequoia Pharmaceuticals, founded in 2002, develops antiviral therapeutics with a special focus on drug-resistant viruses.8 Its lead investors include the Wellcome Trust.
But there’s yet another problem with Sequoia’s 2003 filing for an antiviral agent. It was actually issued and published before the CDC patent on SARS coronavirus had been granted, which didn’t happen until 2007, and the CDC had paid to keep the application private. "
The next bombshell revelation occurred on June 5, 2008, when Ablynx, now a part of Sanofi, filed a series of patents detailing what we’ve been told are novel features of SARS-CoV-2, namely the polybasic cleavage site, the spike protein and the ACE2 receptor binding domain. The first of those patents, U.S. Patent No. 9193780, was issued on November 24, 2015. Between 2016 and 2019, a series of patents were issued to Ablynx and Sanofi covering the RNA strands and the subcomponents of the gene strands.
Between 2008 and 2017, a series of patents were also filed by a long list of players, including Crucell, Rubeus Therapeutics, Children’s Medical Corporation, Ludwig-Maximilians-Universität in München, Protein Science Corporation, Dana-Farber Cancer Institute, University of Iowa, University of Hong Kong and the Chinese National Human Genome Center in Shanghai.
This series of patents detail ever single attribute that is supposed to be unique to SARS-CoV-2, according to the paper, “A Novel Bat Coronavirus Reveals Natural Insertions at the S1/S2 2 Cleavage Site of the Spike Protein and a Possible Recombinant 3 Origin of HCoV-19.”
This paper has routinely been used to identify the so-called novel coronavirus that is SARS-CoV-2. Yet there are 73 patents, issued between 2008 and 2019, that describe the very elements that are said to be unique to SARS-CoV-2. Patents have been filed for SARS-CoV-2’s polybasic cleavage site, the ACE2 receptor binding domain, and the spike protein.
“So, there was no ‘outbreak’ of SARS, because we had engineered all of the elements of that,” Martin says. And by 2016, when Baric published a paper warning that SARS coronavirus was “poised for human emergence,” the virus in question had already been patented for commercial exploitation 73 times!
以下專利是香港機構申請的：
這不是一個中國官方的獎項，而是私人基金會的獎項。就等於諾貝爾和平獎一樣，衹是一個政治工具，來頒獎給利益集團有關係的和人物。這就等於達賴喇嘛，奧巴馬和劉曉波獲奖一樣。
未來科學大獎2016年已成立，為什麼要在2021年才頒獎給袁國勇？袁國勇已經65歲，他已達到退休年齡。他是否會轉職商業機構成為未來的科學家? 這些私人基金會的獎項，就是提昇他們代言人的聲譽，然後為他們的背後的資本集團發聲！他們要保護同盟袁國勇！或交保護費要他閉嘴！根本就是無私顯見私。
真的了不起！！
“人民英雄”國家榮譽稱號獲得者陳薇和鐘南山等，國家班的獎項才是真的英雄！。